AKT1 and diabetic kidney disease: The phosphatidylinositol 3-kinases/protein kinase B/mammalian target of the rapamycin (PI3K/AKT/mTOR) signaling pathway plays an essential role in the implementation of the high glucose effect in diabetic kidney disease and renal fibrosis [14,15,16].